Division of Epidemiology and Clinical Applications, National Eye Institute, National Institutes of Health, Bethesda, Maryland.
Department of Ophthalmology and Visual Sciences, University of Wisconsin-Madison School of Medicine and Public Health, Madison, Wisconsin.
Ophthalmology. 2022 Oct;129(10):1107-1119. doi: 10.1016/j.ophtha.2022.05.021. Epub 2022 May 31.
To analyze reticular pseudodrusen (RPD) as an independent risk factor for progression to late age-related macular degeneration (AMD), alongside traditional macular risk factors (soft drusen and pigmentary abnormalities) considered simultaneously.
Post hoc analysis of 2 clinical trial cohorts: Age-Related Eye Disease Study (AREDS) and AREDS2.
Eyes with no late AMD at baseline in AREDS (6959 eyes, 3780 participants) and AREDS2 (3355 eyes, 2056 participants).
Color fundus photographs (CFPs) from annual visits were graded for soft drusen, pigmentary abnormalities, and late AMD. Presence of RPD was from grading of fundus autofluorescence images (AREDS2) and deep learning grading of CFPs (AREDS). Proportional hazards regression analyses were performed, considering AREDS AMD severity scales (modified simplified severity scale [person] and 9-step scale [eye]) and RPD presence simultaneously.
Progression to late AMD, geographic atrophy (GA), and neovascular AMD.
In AREDS, for late AMD analyses by person, in a model considering the simplified severity scale simultaneously, RPD presence was associated with a higher risk of progression: hazard ratio (HR), 2.15 (95% confidence interval [CI], 1.75-2.64). However, the risk associated with RPD presence differed at different severity scale levels: HR, 3.23 (95% CI, 1.60-6.51), HR, 3.81 (95% CI, 2.38-6.10), HR, 2.28 (95% CI, 1.59-3.27), and HR, 1.64 (95% CI, 1.20-2.24), at levels 0-1, 2, 3, and 4, respectively. Considering the 9-step scale (by eye), RPD presence was associated with higher risk: HR, 2.54 (95% CI, 2.07-3.13). The HRs were 5.11 (95% CI, 3.93-6.66) at levels 1-6 and 1.78 (95% CI, 1.43-2.22) at levels 7 and 8. In AREDS2, by person, RPD presence was not associated with higher risk: HR, 1.18 (95% CI, 0.90-1.56); by eye, it was HR, 1.57 (95% CI, 1.31-1.89). In both cohorts, RPD presence carried a higher risk for GA than neovascular AMD.
Reticular pseudodrusen represent an important risk factor for progression to late AMD, particularly GA. However, the added risk varies markedly by severity level, with highly increased risk at lower/moderate levels and less increased risk at higher levels. Reticular pseudodrusen status should be included in updated AMD classification systems, risk calculators, and clinical trials.
分析网状假性血管病变(RPD)作为晚期年龄相关性黄斑变性(AMD)进展的独立危险因素,同时考虑到被认为是传统黄斑危险因素(软性玻璃膜疣和色素异常)。
对 2 项临床试验队列(年龄相关性眼病研究[AREDS]和 AREDS2)进行的事后分析。
基线时无晚期 AMD 的眼睛,包括在 AREDS(6959 只眼,3780 名参与者)和 AREDS2(3355 只眼,2056 名参与者)中。
对年度就诊的彩色眼底照片(CFPs)进行软玻璃膜疣、色素异常和晚期 AMD 的分级。RPD 的存在来自眼底自发荧光图像(AREDS2)的分级和 CFPs 的深度学习分级(AREDS)。使用比例风险回归分析,同时考虑 AREDS AMD 严重程度分级(改良简化严重程度分级[个体]和 9 步分级[眼])和 RPD 存在情况。
进展为晚期 AMD、地理萎缩(GA)和新生血管性 AMD。
在 AREDS 中,对于个体的晚期 AMD 分析,在同时考虑简化严重程度分级的模型中,RPD 存在与进展的更高风险相关:风险比(HR),2.15(95%置信区间[CI],1.75-2.64)。然而,与 RPD 存在相关的风险在不同的严重程度分级水平上有所不同:HR,3.23(95%CI,1.60-6.51),HR,3.81(95%CI,2.38-6.10),HR,2.28(95%CI,1.59-3.27),和 HR,1.64(95%CI,1.20-2.24),分别在水平 0-1、2、3 和 4。考虑到 9 步分级(眼),RPD 存在与更高的风险相关:HR,2.54(95%CI,2.07-3.13)。HR 分别为 5.11(95%CI,3.93-6.66)在 1-6 级和 1.78(95%CI,1.43-2.22)在 7-8 级。在 AREDS2 中,个体 HR,1.18(95%CI,0.90-1.56);眼 HR,1.57(95%CI,1.31-1.89),RPD 存在与更高的风险无关。在两个队列中,RPD 存在比新生血管性 AMD 更易导致 GA。
网状假性血管病变是晚期 AMD 进展的一个重要危险因素,特别是 GA。然而,风险的增加幅度差异显著,在较低/中度水平时风险显著增加,在较高水平时风险增加幅度较小。RPD 状态应纳入更新的 AMD 分类系统、风险计算器和临床试验中。